Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Revista Colombiana de Reumatología
Print version ISSN 0121-8123
Abstract
ZULUAGA GOMEZ, Liliana María; VELASQUEZ FRANCO, Carlos Jaime; HERNANDEZ FORONDA, John Camilo and CASTANO ALZATE, Carlos Felipe. Rituximab use in a patient with diffuse necrotizing anterior scleritis associated to c-ancas vasculitis refractory to conventional inmunomodulators. Rev.Colomb.Reumatol. [online]. 2012, vol.19, n.3, pp.183-189. ISSN 0121-8123.
Scleritis is a rare disease characterized by inflammation of sclera and underlying infectious or systemic disease. Severe cases can compromise vision and cause scleral necrosis and eye perforation. c-ANCA associated vasculitis, a systemic syndrome could cause scleritis. Traditional treatment consists of antinflammatory and immunomodulators administration. Refractory cases could be treated with monoclonal antibodies. We report the case of a woman with diffuse necrotizing anterior scleritis associated to c-ANCA refractory to immunosupressants, such as cyclophosphamide in which only Rituximab could induce remission.
Keywords : Scleritis; anti-neutrophil cytoplasmic antibody-associated vasculitis; rituximab; therapy.